Allarity Therapeutics A/S — Credit Rating and Financial Key Figures

Allarity Therapeutics A/S (CVR number: 28106351K) is a company from RUDERSDAL. The company reported a net sales of 0.8 mDKK in 2019, demonstrating a decline of -62.7 % compared to the previous year. The operating profit percentage was poor at -18489.6 % (EBIT: -148.1 mDKK), while net earnings were -138.1 mDKK. The profitability of the company measured by Return on Assets (ROA) was -66.9 %, which can be considered poor and Return on Equity (ROE) was -99 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 78 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Allarity Therapeutics A/S's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.